Reboxetine Clinical Trials

• Effect of Escitalopram Vs. Reboxetine on Gastro-Intestinal Sensitivity of Patients with Major Depressive Disorder.
  ClinicalTrials.gov Identifier: NCT00209807 - Recruiting
  Major depression; Pain; Abdominal Pain
  
• Study of [S,S]-Reboxetine in Patients with Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures
  ClinicalTrials.gov Identifier: NCT00143442 - Completed
  Pain
  
• [S,S]-Reboxetine Add-On Trial
  ClinicalTrials.gov Identifier: NCT00334685 - Recruiting
  Pain
  
• A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.
  ClinicalTrials.gov Identifier: NCT00353808 - Active, not recruiting
  Pain
  
• Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
  ClinicalTrials.gov Identifier: NCT00426946 - Recruiting
  Depression
  
• [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.
  ClinicalTrials.gov Identifier: NCT00348894 - Recruiting
  Pain
  
• Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00409201 - Recruiting
  Schizophrenia
  
• Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.
  ClinicalTrials.gov Identifier: NCT00421369 - Not yet recruiting
  Major Depressive Disorder
  
• Hippocampal Volume in Young Patients with Major Depression Before and After Combined Antidepressive Therapy
  ClinicalTrials.gov Identifier: NCT00150839 - Recruiting
  Depressive Disorder, Major
  
• [S,S]-Reboxetine Dose-Range Finding Trial
  ClinicalTrials.gov Identifier: NCT00288652 - Completed
  Pain
  
• A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00357825 - Completed
  Pain
  
• Evaluation of A Novel Methodology in the Assessment of Urethral Function Using [S,S]-Reboxetine in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00444548 - Completed
  Healthy
  
• [S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
  ClinicalTrials.gov Identifier: NCT00354094 - Terminated
  Pain
  
• Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
  ClinicalTrials.gov Identifier: NCT00562055 - Terminated
  Attention Deficit Hyperactivity Disorder